Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
39.80
+0.46 (1.17%)
Nov 21, 2024, 4:00 PM EST - Market closed

Xenon Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
259
Market Cap
3.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 20229.43M-9.00M-48.83%
Dec 31, 202118.44M-13.73M-42.68%
Dec 31, 202032.17M25.34M371.02%
Dec 31, 20196.83M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Surgery Partners 2.99B
Amedisys 2.32B
LivaNova 1.24B
HUTCHMED (China) 610.81M
Inari Medical 574.50M
Veracyte 425.33M
Merus 35.93M
Revenue Rankings